BCR signaling during B cell development and maintenance

B 细胞发育和维持期间的 BCR 信号传导

基本信息

  • 批准号:
    7172962
  • 负责人:
  • 金额:
    $ 56.49万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2003
  • 资助国家:
    美国
  • 起止时间:
    2003-02-15 至 2008-01-31
  • 项目状态:
    已结题

项目摘要

A major determinant in the development, selection and differentiation of B lymphocytes is the B cell antigen receptor (BCR) whose antibody variable regions recognize antigen and whose signaling unit (the Igod_ he- terodimer) transmits signals into the interior of the cell. Signaling pathways activated by Igod_ cytoplasmic tails control the response of the cells to antigenic selection including tolerance induction by antigen to avoid autoimmunity and antibody responses to pathogens. BCR signaling also seems to be required for mature B cell survival. Signaling through the cytoplasmic tails of Ig(x/_ requires phosphorylation of tyrosine-based ac- tivation motifs termed ITAMs. However, there is evidence mainly from work on cell lines that other con- served targets of phosphorylation in these tails including serine and threonine residues also contribute to sig- nal transduction. The present proposal aims at defining the role of these residues in B cell development and activation in the in vivo context, using targeted mutagenesis in the mouse. We will similarly analyze the roles of the cytoplasmic tails in the maintenance of mature B cells and their interplay with B-cell activation factor- mediated survival, using systems of inducible gene targeting. Knowledge about the control of B cell survival is critical for an understanding of B cell homeostasis and therapeutic intervention in B cell-mediated auto- immunity and B cell lymphoma growth. In a final part of the proposal, we will address to which extent the differentiation of B cells into the B-1 and B-2 subsets is driven by BCR specificities which are unequally distributed between the two subsets. B-1 cells are thought to play a major role in natural immune defense and to be prone to autoantibody production, whereas B-2 cells are the major players in adaptive antibody re- sponses. We will use a genetic switch allowing the cells to switch in vivo from the expression of a B-I- typical to a B-2-typical BCR and vice versa, to determine to which extent the B-1 and B-2 phenotypes re- present distinct states of activation as opposed to being determined by distinct developmental programs. This will be complemented by an attempt to switch mature B-2 ceils to a B-1 phenotype by induced inactivation of SHP- 1 phosphatase whose inactivation in B cell progenitors leads to near-exclusive production of B- 1 cells.
B淋巴细胞的发育、选择和分化的主要决定因素是B细胞抗原 受体(BCR),其抗体可变区识别抗原,并且其信号传导单位(Igod_ he- terodimer)将信号传递到细胞内部。Igod_细胞质激活的信号通路 尾部控制细胞对抗原选择的反应,包括抗原诱导的耐受性, 自身免疫和对病原体的抗体反应。BCR信号传导似乎也是成熟B所需的 细胞存活通过IG(x/_)的胞质尾部的信号传导需要酪氨酸基ac-磷酸化。 激活基序称为ITAM。然而,有证据表明,主要是从工作的细胞系,其他CON- 在这些尾部中的磷酸化作用靶点,包括丝氨酸和苏氨酸残基,也有助于信号转导。 终末转导本提案旨在确定这些残基在B细胞发育中的作用, 在小鼠中使用靶向诱变在体内环境中激活。我们将类似地分析角色 成熟B细胞维持中的胞质尾区及其与B细胞活化因子的相互作用- 介导的生存,使用诱导基因靶向系统。关于控制B细胞存活的知识 是理解B细胞稳态和治疗干预B细胞介导的自体免疫的关键。 免疫和B细胞淋巴瘤生长。在提案的最后一部分,我们将讨论在何种程度上 B细胞分化为B-1和B-2亚群是由BCR特异性驱动的, 分布在两个子集之间。B-1细胞被认为在天然免疫防御中起主要作用, 容易产生自身抗体,而B-2细胞是适应性抗体重新产生的主要参与者。 海绵。我们将使用一个基因开关,允许细胞在体内从表达B-I- 典型BCR与B-2-典型BCR之间的关系,反之亦然,以确定B-1和B-2表型在多大程度上与典型BCR之间的关系。 呈现不同的激活状态,而不是由不同的发育程序决定。这 将通过尝试将成熟B-2细胞转化为B-1表型来补充, SHP- 1磷酸酶,其在B细胞祖细胞中的失活导致B- 1细胞的几乎排他性的产生。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

KLAUS RAJEWSKY其他文献

KLAUS RAJEWSKY的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('KLAUS RAJEWSKY', 18)}}的其他基金

The Role of B-Cell Receptor and NF<B in Germinal Center B-Cell Lymphomas
B 细胞受体和 NF<B 在生发中心 B 细胞淋巴瘤中的作用
  • 批准号:
    7156134
  • 财政年份:
    2006
  • 资助金额:
    $ 56.49万
  • 项目类别:
Role of RNA silencing in B cell development and function
RNA 沉默在 B 细胞发育和功能中的作用
  • 批准号:
    6902989
  • 财政年份:
    2005
  • 资助金额:
    $ 56.49万
  • 项目类别:
Role of RNA silencing in B cell development and function
RNA 沉默在 B 细胞发育和功能中的作用
  • 批准号:
    7367061
  • 财政年份:
    2005
  • 资助金额:
    $ 56.49万
  • 项目类别:
Role of RNA silencing in B cell development and function
RNA 沉默在 B 细胞发育和功能中的作用
  • 批准号:
    7017769
  • 财政年份:
    2005
  • 资助金额:
    $ 56.49万
  • 项目类别:
Role of RNA silencing in B cell development and function
RNA 沉默在 B 细胞发育和功能中的作用
  • 批准号:
    7196405
  • 财政年份:
    2005
  • 资助金额:
    $ 56.49万
  • 项目类别:
Role of RNA silencing in B cell development and function
RNA 沉默在 B 细胞发育和功能中的作用
  • 批准号:
    7572950
  • 财政年份:
    2005
  • 资助金额:
    $ 56.49万
  • 项目类别:
IKK Signals in Lymphocyte Physiology and Pathology
淋巴细胞生理学和病理学中的 IKK 信号
  • 批准号:
    7154078
  • 财政年份:
    2003
  • 资助金额:
    $ 56.49万
  • 项目类别:
IKK Signals in Lymphocyte Physiology and Pathology
淋巴细胞生理学和病理学中的 IKK 信号
  • 批准号:
    6830767
  • 财政年份:
    2003
  • 资助金额:
    $ 56.49万
  • 项目类别:
BCR signaling during B cell development and maintenance
B 细胞发育和维持期间的 BCR 信号传导
  • 批准号:
    6702282
  • 财政年份:
    2003
  • 资助金额:
    $ 56.49万
  • 项目类别:
TOWARDS A MOUSE MODEL OF CLASSICAL HODGKIN'S DISEASE
经典霍奇金病的小鼠模型
  • 批准号:
    6904702
  • 财政年份:
    2003
  • 资助金额:
    $ 56.49万
  • 项目类别:

相似海外基金

University of Aberdeen and Vertebrate Antibodies Limited KTP 23_24 R1
阿伯丁大学和脊椎动物抗体有限公司 KTP 23_24 R1
  • 批准号:
    10073243
  • 财政年份:
    2024
  • 资助金额:
    $ 56.49万
  • 项目类别:
    Knowledge Transfer Partnership
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
  • 批准号:
    10752129
  • 财政年份:
    2024
  • 资助金额:
    $ 56.49万
  • 项目类别:
CAREER: Next-generation protease inhibitor discovery with chemically diversified antibodies
职业:利用化学多样化的抗体发现下一代蛋白酶抑制剂
  • 批准号:
    2339201
  • 财政年份:
    2024
  • 资助金额:
    $ 56.49万
  • 项目类别:
    Continuing Grant
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
  • 批准号:
    MR/Y008693/1
  • 财政年份:
    2024
  • 资助金额:
    $ 56.49万
  • 项目类别:
    Research Grant
Developing first-in-class aggregation-specific antibodies for a severe genetic neurological disease
开发针对严重遗传神经系统疾病的一流聚集特异性抗体
  • 批准号:
    10076445
  • 财政年份:
    2023
  • 资助金额:
    $ 56.49万
  • 项目类别:
    Grant for R&D
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
  • 批准号:
    23K14783
  • 财政年份:
    2023
  • 资助金额:
    $ 56.49万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms controlling the physicochemical properties and functions of supercharged antibodies and development of their applications
阐明控制超电荷抗体的理化性质和功能的机制及其应用开发
  • 批准号:
    23KJ0394
  • 财政年份:
    2023
  • 资助金额:
    $ 56.49万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Role of antibodies in hepatitis E virus infection
抗体在戊型肝炎病毒感染中的作用
  • 批准号:
    10639161
  • 财政年份:
    2023
  • 资助金额:
    $ 56.49万
  • 项目类别:
Defining the protective or pathologic role of antibodies in Post-Ebola Syndrome
定义抗体在埃博拉后综合症中的保护或病理作用
  • 批准号:
    10752441
  • 财政年份:
    2023
  • 资助金额:
    $ 56.49万
  • 项目类别:
Human CMV monoclonal antibodies as therapeutics to inhibit virus infection and dissemination
人 CMV 单克隆抗体作为抑制病毒感染和传播的治疗药物
  • 批准号:
    10867639
  • 财政年份:
    2023
  • 资助金额:
    $ 56.49万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了